• EZ Cap™ Mouse IL-12 mRNA (m1Ψ) Workflow

  2026-08-22

  Build reproducible cytokine-expression assays with a capped, polyadenylated Mouse Interleukin-12 mRNA designed for efficient translation and reduced innate immune activation. This guide connects practical handling and dose-finding with emerging extrahepatic delivery strategies for immunotherapy research mRNA.

• Busulfan Workflows for Senescence and Germ Cell Models

  2026-08-22

  Busulfan supports two complementary research use cases: stress-driven senescence induction in WI38 fibroblasts and experimental germ-cell depletion in mice. This guide connects those workflows with dual-recombinase lineage tracing, practical preparation parameters, and troubleshooting strategies that help distinguish tissue injury from genuine cellular regeneration.

• Lipid Peroxidation (MDA) Assay Kit in Ferroptosis

  2026-08-21

  The Lipid Peroxidation (MDA) Assay Kit connects quantitative malondialdehyde measurement with ferroptosis research in sepsis-associated acute kidney injury. This guide emphasizes pathway-informed assay design, matrix control, orthogonal validation, and interpretation beyond a single oxidative stress endpoint.

• CH 223191 in AhR-Driven Ovarian Toxicity

  2026-08-20

  CH 223191 is an aryl hydrocarbon receptor antagonist for testing whether AhR activation causally links environmental exposures to ovarian follicle dysfunction. This article translates recent mouse follicle findings into a rigorous assay strategy that integrates pathway, hormone, and tissue-level endpoints.

• Rotigotine Patch: Continuous Dopaminergic Delivery

  2026-08-20

  The reference review explains how rotigotine’s lipid solubility, dopamine-receptor pharmacology, and sustained skin delivery enabled development of a 24-hour transdermal system for Parkinson’s disease and restless legs syndrome. Its main translational insight is that stable exposure may reduce the limitations of short-acting, pulsatile dopaminergic treatment, although clinical benefits must be interpreted alongside patch-specific tolerability and disease-specific uncertainties.

• S Tag Peptide: Practical Fusion Tag Guide

  2026-08-19

  S Tag Peptide supports recombinant protein detection, antibody-based capture, and protein solubility improvement when used as an encoded N- or C-terminal S-peptide fusion tag. The supplied free peptide is water- and DMSO-soluble but should not be treated as an independently active ribonuclease fragment, used in ethanol, or stored long term in solution.

• Exo1: A Mechanistic Roadmap for Translational Research

  2026-08-19

  Exo1 provides a mechanism-focused way to interrogate Golgi–ER traffic, ARF1 behavior, and exocytic control. This thought-leadership article connects that cellular tool to emerging tumor extracellular vesicle research while defining the evidence, controls, and translational limits needed for responsible interpretation.

• Decitabine: Designing Immune-Epigenetic Assays

  2026-08-18

  Decitabine and 5-Aza-2'-deoxycytidine can do more than erase aberrant DNA methylation. This article presents a phenotype-first framework for separating tumor-cell reprogramming from immune-cell remodeling, grounded in low-dose T-cell evidence and practical assay decisions.

• miRNA–mRNA Control of Juvenile Hormone Biosynthesis

  2026-08-18

  The reference study identifies coordinated miRNA–mRNA modules that relieve post-transcriptional repression of juvenile hormone biosynthetic genes during locust vitellogenesis. Its combination of transcriptomics, target validation, and agomiR perturbation connects juvenile hormone production with vitellogenin expression and ovarian development, providing a framework for studying endocrine control of insect reproduction.

• BVDV Glycolytic Reprogramming and MAVS Evasion

  2026-08-17

  The reference study identifies a ROS–HIF-1α–glycolysis pathway through which bovine viral diarrhea virus suppresses RIG-I/MAVS signaling and increases viral replication. Its integration of redox, metabolic, protein-complex, lactate, interferon, and replication readouts provides a useful framework for dissecting metabolism-dependent antiviral immune evasion.

• Porcupine Inhibition in Severe Sclerosteosis

  2026-08-17

  A 2025 Bone Research study tested LGK974, a PORCN inhibitor, as a pharmacological strategy for the excessive Wnt activity underlying SOST-deficient sclerosteosis. Cell and mouse experiments showed reduced osteoblast activity and pathological bone accumulation, while also identifying sex-dependent differences in molecular target engagement.

• MDV3100 (Enzalutamide) Research Workflows

  2026-08-16

  MDV3100 (Enzalutamide) provides a practical way to interrogate androgen receptor signaling, apoptosis, metastasis, and treatment resistance across prostate cancer models. This guide translates product specifications and recent AR/ARv7 findings into executable workflows, assay choices, and troubleshooting strategies.

• EPI-001: Reframing AR-Driven Resistance

  2026-08-15

  EPI-001 is an androgen receptor N-terminal domain inhibitor that provides a mechanistically distinct way to study full-length AR and ligand-independent signaling. This thought-leadership analysis connects prostate cancer research with emerging AR/ARv7 biology in triple-negative breast cancer while defining practical translational workflows and evidence boundaries.

• Neuroligin 1 Proteolysis Sustains Social Memory

  2026-08-14

  Liu et al. identify a previously unrecognized maintenance mechanism in which social interaction triggers α- and γ-secretase processing of Neuroligin 1 in the ventral hippocampus. The resulting intracellular NLG1-CTD fragment engages its PDZ-binding domain and cofilin signaling to preserve synaptic structure and short-term social memory, offering a mechanistic link between extracellular proteolysis and memory maintenance.

• Omeprazole (A2845): Practical Workflow Guide

  2026-08-14

  This guide explains how to use Omeprazole (SKU A2845) in H+,K+-ATPase inhibition and gastric acid secretion research while addressing its water insolubility and solution-stability constraints. It is intended for controlled scientific assays only, not for diagnostic, medical, or therapeutic use.

7901 records 1/527 page Next 12345 下5页 Last page